Stocks Telegraph

BNOX Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:BNOX

Bionomics Limited

$0.60
-0.0103-1.70%
At Close 4:00 PM
50
BESG ScoreESG Rating
Loading...

Stock Price Today

Bionomics Limited (BNOX) stock declined over -1.70%, trading at $0.60 on NASDAQ, down from the previous close of $0.61. The stock opened at $0.59, fluctuating between $0.58 and $0.64 in the recent session.

Stock Snapshot

0.6053
Prev. Close
0.59
Open
7.11M
Market Cap
11.95M
Number of Shares
0.58
Day Low
0.644
Day High
-0.29
P/E Ratio
11,296.83%
Free Float in %
-2.05
EPS (TTM)
2.09
Book Value
-1.51
Cash Flow per Share
45.64K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Sep 06, 20240.590.640.580.6045.28K
Sep 05, 20240.630.670.600.6191.6K
Sep 04, 20240.610.650.590.6326.76K
Sep 03, 20240.620.640.580.6060.85K
Aug 30, 20240.650.670.610.6498.8K
Aug 29, 20240.670.690.620.64150.5K
Aug 28, 20240.670.700.660.69111.7K
Aug 27, 20240.680.700.650.6999.89K
Aug 26, 20240.650.690.650.6998.88K
Aug 23, 20240.630.680.620.68112.41K
Aug 22, 20240.690.690.570.63117.9K
Aug 21, 20240.640.670.610.6498.2K
Aug 20, 20240.600.650.580.64248.47K
Aug 19, 20240.550.600.550.58136.72K
Aug 16, 20240.560.620.550.5993K
Aug 15, 20240.560.600.530.58218.67K
Aug 14, 20240.550.590.540.56374.71K
Aug 13, 20240.620.640.590.61130.6K
Aug 12, 20240.620.640.600.62170.65K
Aug 09, 20240.600.620.580.60267.83K

Contact Details

Eastwood, SA 5063

Australia

Website: https://www.bionomics.com.auContact: 618 835 46100

About Company

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder. It also develops BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, a vascular disrupting agent, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer, and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited has a licensing agreement with Merck & Co., Inc. The company was incorporated in 1996 and is based in Eastwood, Australia.

Company Information

Employees8
Beta-0.123
Sales or Revenue$432.67K
5Y Sales Change%-0.984%
Fiscal Year EndsJune
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Bionomics Limited (BNOX) stock price?

Bionomics Limited (NASDAQ: BNOX) stock price is $0.60 in the last trading session. During the trading session, BNOX stock reached the peak price of $0.64 while $0.58 was the lowest point it dropped to. The percentage change in BNOX stock occurred in the recent session was -1.7% while the dollar amount for the price change in BNOX stock was -$0.01.

BNOX's industry and sector of operation?

The NASDAQ listed BNOX is part of Biotechnology industry that operates in the broader Healthcare sector. Bionomics Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BNOX?

No Data

How BNOX did perform over past 52-week?

BNOX's closing price is 19% higher than its 52-week low of $0.50 where as its distance from 52-week high of $6.41 is -90.72%.

How many employees does BNOX have?

Number of BNOX employees currently stands at 8.

Link for BNOX official website?

Official Website of BNOX is: https://www.bionomics.com.au

How do I contact BNOX?

BNOX could be contacted at phone 618 835 46100 and can also be accessed through its website. BNOX operates from 200 Greenhill Road, Eastwood, SA 5063, Australia.

How many shares of BNOX are traded daily?

BNOX stock volume for the day was 45.64K shares. The average number of BNOX shares traded daily for last 3 months was 962.61K.

What is the market cap of BNOX currently?

The market value of BNOX currently stands at $7.11M with its latest stock price at $0.60 and 11.95M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Login Form

OR
stockstelegraph

Join to access AI-powered insights from top Wall Street analysts.

Signup Form

OR
stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Reset Password Form

stockstelegraph

Subscribe to gain access to powerful insights powered by AI and Wallstreet analysts.

This feature is only available to Premium Users.

Subscribe Now